Delivery Order SPE2DB22D1106-SPE2DB24FEXY4
- Not listed
- This federal contract award, valued at $2,546.15, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of CELEBREX 200 MG CAPSULE 100S, a pharmaceutical product, to support the DLA's mission. The contract has an ultimate completion date of July 31, 2024, and is a Firm Fixed Price Delivery Order. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,619.93 firm fixed price delivery order is for the supply of 100 milligram Celebrex capsules. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,674.63, is for the delivery of Celebrex 200 mg capsules to support military healthcare programs. It is a firm-fixed price delivery order contract with a completion date of June 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $168,352.87 firm fixed-price delivery order contract is for the delivery of CELEBREX 200MG 100S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $166,072.60 firm fixed-price delivery order contract is for the supply of Celebrex 200mg medication, a commonly prescribed drug for the treatment of pain and inflammation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,697.16, is for the delivery of Celecoxib 200 mg capsules to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 21, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite...
- This federal contract award, valued at $1,050.78, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of Celecoxib 200mg medication, a non-set-aside requirement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,248.98, is for the delivery of 4,567,886,446 units of the drug Celecoxib 200 mg capsules. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $1,441.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,174,033 units of the medication Celecoxib 200 mg capsule, with a completion date of May 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $25,773.44, is for the delivery of 4566367910 Celecoxib 200 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 1, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEXY4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at up to $10,857.00, is for the delivery of CELEBREX 200 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of June 21, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 6/20/24 |